Ipsen (ENXTPA:IPN) announced a global collaboration and option agreement with Origami Therapeutics. The partnership focuses ...
7d
Origami Therapeutics Announces Global Collaboration with Ipsen to Advance Protein Degrader Program
Origami Therapeutics, a biotech company developing small molecule protein degraders and conformation correctors to treat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results